Strengthening FDA’s Regulatory Readiness: Implementing Lessons Learned from the COVID-19 Pandemic

2024-10-292024-10-292021-09-30https://hdl.handle.net/20.500.14300/1978The Senate Committee on Health, Education, Labor and Pensions issued a Minority Oversight Record on FDA expedition of the development and authorization of COVID-19 vaccines, therapeutics, and tests. The record discussed the challenges and congressional action taken to enhance capacity and supply chain resilience for future public health emergencies.6 pagesenOversight RecordsStrengthening FDA’s Regulatory Readiness: Implementing Lessons Learned from the COVID-19 PandemicSenate Minority Oversight Record3: Health331: Public Health and Disease Prevention117